| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 7,441 | 2,979 | 5,094 | 7,095 | | Cost of Revenue | 5,890 | 1,934 | 3,865 | 6,183 | | | Gross Profit | 1,551 | 1,045 | 1,229 | 912 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,476 | 3,150 | 3,162 | 5,185 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,925) | (2,105) | (1,933) | (4,273) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 262 | (378) | (48) | (119) | | Earnings Before Interest And Taxes | (3,595) | (2,483) | (1,981) | (4,392) | | Interest Expense | (1,229) | 537 | 692 | 1,601 | | Income Before Tax | (2,366) | (3,020) | (2,673) | (5,993) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,366) | (3,020) | (2,673) | (5,993) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,366) | (3,020) | (2,673) | (5,993) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,366) | ($3,020) | ($2,673) | ($5,993) |
|
0.51% Nasdaq 
0.02 (10.00%) 
Income Statement
